MedTech Acquisition Alpha and Beta Analysis
| MTACWDelisted Stock | USD 0.10 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MedTech Acquisition. It also helps investors analyze the systematic and unsystematic risks associated with investing in MedTech Acquisition over a specified time horizon. Remember, high MedTech Acquisition's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MedTech Acquisition's market risk premium analysis include:
Beta (5.99) | Alpha 6.15 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
MedTech |
MedTech Acquisition Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MedTech Acquisition market risk premium is the additional return an investor will receive from holding MedTech Acquisition long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MedTech Acquisition. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MedTech Acquisition's performance over market.| α | 6.15 | β | -6 |
MedTech Acquisition Fundamentals Vs Peers
Comparing MedTech Acquisition's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MedTech Acquisition's direct or indirect competition across all of the common fundamentals between MedTech Acquisition and the related equities. This way, we can detect undervalued stocks with similar characteristics as MedTech Acquisition or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MedTech Acquisition's fundamental indicators could also be used in its relative valuation, which is a method of valuing MedTech Acquisition by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MedTech Acquisition to competition |
| Fundamentals | MedTech Acquisition | Peer Average |
| Number Of Shares Shorted | 7.89 K | 4.71 M |
| EBITDA | (8.58 M) | 3.9 B |
| Net Income | 5.54 M | 570.98 M |
| Cash And Equivalents | 25 K | 2.7 B |
| Total Debt | 2.37 M | 5.32 B |
| Debt To Equity | 1.77 % | 48.70 % |
| Cash Flow From Operations | (2.74 M) | 971.22 M |
MedTech Acquisition Opportunities
MedTech Acquisition Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Sanara MedTech Inc. Announces First Quarter 2023 Results - Yahoo Finance | 05/15/2023 |
2 | AI in medtech MA - Todays Medical Developments | 06/02/2023 |
3 | Analyst calls of the week Palo Alto upped, Carnival earnings ... - Proactive Investors USA | 06/16/2023 |
About MedTech Acquisition Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MedTech or other delisted stocks. Alpha measures the amount that position in MedTech Acquisition has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MedTech Acquisition in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MedTech Acquisition's short interest history, or implied volatility extrapolated from MedTech Acquisition options trading.
Build Portfolio with MedTech Acquisition
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |